Board of Directors: |
| President |
 |
Gabriela Tannus Branco de Araújo, MBA
Health Economics Director
Axia.Bio Consulting, São Paulo
Email: Gabriela.tannus@axia.bio.br |
| President-Elect |
 |
Stephen Stefani, MD
Medical Auditor, Head of Oncology Unit
UNIMED, Porto Alegre
Email: stephens@terra.com.br |
| Secretary |
 |
Alessandra Costa Clemente Marques
Health Economics Manager
Eli Lilly, São Paulo
Email: marquesal@lilly.com |
| Treasurer |
|
Carlos Eduardo Borges
Sales Manager
Bayer Health Care, São Paulo
Email: eduardo.borges@bayerhealthcare.com |
| Management |
 |
Wilson Follador PhD, PharmD, MSc
Manager of Pharmacoeconomics
Pfizer Laboratories, São Paulo
Email: wilson.follador@pfizer.com |
| |
 |
Marcos Bosi Ferraz MD, PhD, MSc
Professor and Director
São Paulo Center for Health Economics
Federal University of São Paulo, São Paulo
Email: marcos.ferraz@fleury.com.br |
| |
 |
Alessandra Calabró, MBA
Market Access & Business Intelligence Manager
Oncology Unit
Novartis, São Paulo
Email: alessandra.calabro@novartis.com |
| |
 |
Denizar Vianna Araujo, MD, MSc, PhD
Associate Professor
Department of Internal Medicine
State University of Rio de Janeiro, Rio de Janeiro
Email: denizarvianna@medinsight.com |
| |
 |
Marcelo Cunio Machado Fonseca MD, MSc
Clinical Manager
Federal University of São Paulo, São Paulo
AxiaBio Consulting, São Paulo
Email: marcelo.fonseca@axia.bio.br |
| |
|
Marcelo Liebhardt, PhD, MSc
Economic Manager
Interfarma, São Paulo
Email: marcelo@interfarma.com |
| |
 |
Rachel Wapf
Secretary
ISPOR Brazil
Email: secretaria@ispor.org.br |
|
